期刊文献+

大肠癌患者化疗前后证素变化的初步探讨 被引量:5

Colorectal Cancer before and after Chemotherapy in Patients with Syndrome Elements Change of Preliminary Discussion
下载PDF
导出
摘要 目的观察大肠癌患者奥沙利铂化疗前后过程中证素演变的特点,为中西医联合用药提供参考方案。方法采集48例接受奥沙利铂化疗的大肠癌患者的四诊信息,运用证素辨证法提取证素,观察化疗前后临床症状、证素变化情况。结果 48例患者化疗后手足麻木、疲乏、食欲减退、恶心呕吐发生频率增加(P<0.05),化疗后病性证素阴虚、血虚、气虚和病位证素脾、肾频数显著增加(P<0.05)。结论大肠癌患者在化疗过程中证素会发生变化,主要是因化疗药物损伤气、血、津液等而引起以虚证为主的变化。 Objective To observe the characteristics of evolution of syndrome elements of oxaliplatin in patients with colorectal cancer before and after chemotherapy in the process, and the therapy of traditional Chinese medicine and Western medicine to provide reference. Methods Collect 48 colorectal cancer patients received oxaliplatin hemotherapy with TCM diagnostic information, use syndrome elements differentiation to get the syndrome elements, observe the clinical symptoms and the changes of syndrome elements before and after chemotherapy. Results 48 cases of numbness, fatigue, loss of appetite decline in patients after chemotherapy, nausea and vomit an increase in the frequency of occurrence (P〈0.05), chemotherapy after disease of syndrome elements of yin deficiency, blood deficiency, Qi deficiency and disease syndrome spleen and kidney frequency significantly increased (P〈0.05). Conclusion The change of syndrome elements in patients with of colorectal cancer during chemotherapy, the main reason is the hemotherapy drugs on the human body, qi, blood and fluid damage, in which is the main cause of deficiency syndrome.
出处 《云南中医学院学报》 2015年第6期45-47,共3页 Journal of Yunnan University of Traditional Chinese Medicine
基金 国家自然科学基金(81273666)
关键词 大肠癌 奥沙利铂 证素 colorectal cancer oxaliplatin syndrome elements
  • 相关文献

参考文献14

  • 1Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin, 2011,61 ( 2 ): 69-90.
  • 2陆再英,钟南山.内科学[M].北京:人民卫生出版社,2012:336-337.
  • 3Kelly H,Goldberg RM. Systemic therapy for metastatic col-orectal cancer : current options, current evidence [J]. J ClinOncol,2005,23(20): 4553-4560.
  • 4Aggarwal S,Chu E. Current therapies for advanced colorec-tal cancer[J]. Oncology(Williston Park),2005,19(5):589-595.
  • 5Cassidy J, Misset JL. Oxaliplatin -related side effects : char-acteristics and management [J], Semin Oncol, 2002,29(5Suppl 15):11-20.
  • 6中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治规范(第3分册)[M].北京医科大学、中国协和医科大学联合出版社,1990:15-18,31.
  • 7Jemal A,Siegel R,Ward E,et al. Cancer statistics 2009[J].CA Cancer J Clin. 2009,59(4):225-249.
  • 8Ferlay J,Autier P,Boniol M,et al. Estimates of the cancerincidence and mortality in Europe in 2006 [J]. Ann Oncol,2007,18(3):581-592.
  • 9王双双,关景明,范玉晶.大肠癌发病的相关因素[J].世界华人消化杂志,2005,13(4):534-536. 被引量:32
  • 10Ferlay J,Shin HR,Bray F,et al. Estimates of worldwideburden of cancer in 2008 : GLOBOCAN 2008 [J]. Int JCancer,2010,127(12) :2893-2917.

二级参考文献69

共引文献98

同被引文献55

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部